Znanstveni rad - Izvorni znanstveni rad
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases
Biomedicines, 12 (2024), 2; 331. https://doi.org/10.3390/biomedicines12020331

Aurer, Igor; Jakšić, Ozren; Bašić-Kinda, Sandra; Mrđenović, Stefan; Ostojić-Kolonić, Slobodanka; Lozić, Dominik; Holik, Hrvoje; Novaković-Coha, Sabina; Berneš, Petra; Krečak, Ivan; Morić-Perić, Martina; Narančić, Marino; Mitrović, Zdravko; Valković, Toni

Citirajte ovaj rad

Aurer, I., Jakšić, O., Bašić Kinda, S., Mrđenović, S., Ostojić Kolonić, S., Lozić, D. ... Valković, T. (2024). Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases. Biomedicines, 12. (2). doi: 10.3390/biomedicines12020331

Aurer, Igor, et al. "Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases." Biomedicines, vol. 12, br. 2, 2024. https://doi.org/10.3390/biomedicines12020331

Aurer, Igor, Ozren Jakšić, Sandra Bašić Kinda, Stefan Mrđenović, Slobodanka Ostojić Kolonić, Dominik Lozić, Hrvoje Holik, et al. "Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases." Biomedicines 12, br. 2 (2024). https://doi.org/10.3390/biomedicines12020331

Aurer, I., et al. (2024) 'Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases', Biomedicines, 12(2). doi: 10.3390/biomedicines12020331

Aurer I, Jakšić O, Bašić Kinda S, Mrđenović S, Ostojić Kolonić S, Lozić D, i sur.. Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases. Biomedicines [Internet]. 31.01.2024. [pristupljeno 07.07.2024.];12(2). doi: 10.3390/biomedicines12020331

I. Aurer, et al., "Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases", Biomedicines, vol. 12, br. 2, Siječanj 2024. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:877674. [Citirano: 07.07.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.